BBLG Q4 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$277,629

Net Income

-$531,147

EPS (Diluted)

$76.48

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$297,689

Free Cash Flow

-$297,689

Stock-Based Comp.

$3,126

Balance Sheet

Total Assets

$30,827

Total Liabilities

$12M

Stockholders' Equity

-$12M

Cash & Equivalents

$24,145

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$277,629	-$1M	+77.6%
Net Income	-$531,147	-$1M	+63.9%